drugset / Trial / NCT06019559
A Study to Evaluate the Safety, Tolerability, and Weight Loss Efficacy of K-757 Alone and in Combination With K-833
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a study to evaluate the safety and efficacy of K-757 alone and in combination with K-833 versus placebo in participants who are obese.
Timeline
- Start
- 2023-09-15
- Primary completion
- 2024-02-07
- Completion
- 2024-02-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | K-757 | Unknown | 120 mg | Oral |
| Subject | K-833 | Unknown | 100 mg | Oral |